A conversational discussion (YouTube video) about breast implants and ‘breast implant illness’ that emphasizes nuance between polarized views. Speakers describe a spectrum of experiences—from no issues to significant health complaints—and note increasing public and regulatory attention (including FDA hearings). The tone is conversational and exploratory.
Chapters
So black and white. It needs more gray. There's lots of nuances. Like, the problem is, people are either, I love implants, implants are great. Mine have not done anything, or I have breast implant illness. For me, I feel like I am sort of in the gray. There were things that weren't adding up, that were not making me feel good, but it wasn't one camp or the other. When I started to recognize those signs over and over, like little breadcrumbs, I wanted to do something about it. But I don't think that it has to be, like, so black and white, because not everyone is not the same. We're all different. We're all, like you said, different genetic makeups. There's such a fight over this, and it's not. I feel like there would be more easy conversation if people could just have a normal conversation about it, like we're doing right now, as opposed to, like, so. Well, so fighty.
I look at it pretty simply. There's. I think a lot of people just aren't aware of the potential downsides to getting an implant. You only, you know, people don't talk that you could have these, like. I mean, I've known Lauren a long time. There was never conversations of, hey, you could experience inflammation, or you could experience rashes, or you could experience. I don't think people correlate the two. And so this is. You know, more and more people are talking about this, and I think it's a fight because many have not had the experience of a poor experience, and others are like, whoa, I've solved everything that was going on in my system. Yeah.
In2019, they had a series of hearings that I testified at the FDA in Bethesda. This is about implants and breast implant illness. And so this is mainstream with the fda.